Home » Topics » Regulatory

Regulatory
RSS

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Generic etodolac approved by FDA

July 11, 1997

Sparta's Spartaject busulfan enters phase I

July 11, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

New clinical uses of risperidone investigated

July 10, 1997

Nefazodone evaluated for social phobia

July 10, 1997

Preclinical and clinical antidepressant properties of tolcapone

July 10, 1997

Promising preliminary results from open trial of lamotrigine in depression

July 9, 1997

NKH-477 possesses antidepressant effects

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...